This article is a classic reference on this common but poorly understood group of disorders. It is well worth studying if you are interested in this topic. The large group of illnesses that fall under the rubric of Medically Unexplained Symptoms are functional somatic syndromes.
Functional
somatic syndromes.
Barsky
AJ, Borus JF.
Ann
Intern Med. 1999 Jun 1;130(11):910-21
Link to download of Full Text of article.
The term functional somatic syndrome has been applied to several related syndromes characterized more by symptoms, suffering, and disability than by consistently demonstrable tissue abnormality. These syndromes include multiple chemical sensitivity, the sick building syndrome, repetition stress injury, the side effects of silicone breast implants, the Gulf War syndrome, chronic whiplash, the chronic fatigue syndrome, the irritable bowel syndrome, and fibromyalgia. Patients with functional somatic syndromes have explicit and highly elaborated self-diagnoses, and their symptoms are often refractory to reassurance, explanation, and standard treatment of symptoms.
Friday, February 16, 2018
Sunday, February 11, 2018
The Medical-Industrial Complex
This is the classic first article about the medical-industrial complex. It first appeared in the New England Journal of Medicine in 1980. It is an imporant article, maybe needing to be updated. My own feeling is that the concept of the Medical-Industrial-Academic Complex is more important -- but academics control what gets into our journals. The most prestigious journals tend to benefit greatly from advertising dollars (can skew content) and the authors of scholarly articles are academics. That focuses the literature on what academics feel is important. Thus they report on diseases much more than illnesses.
The Medical-Industrial Complex
Arnold Relman
NEJM 1980; 303:963-970
ABSTRACT: The most important health-care development of the day is the recent, relatively unheralded rise of a huge new industry that supplies health-care services for profit. Proprietary hospitals and nursing homes, diagnostic laboratories, home-care and emergency-room services, hemodialysis, and a wide variety of other services produced a gross income to this industry last year of about $35 billion to $40 billion. This new "medical-industrial complex" may be more efficient than its nonprofit competition, but it creates the problems of overuse and fragmentation of services, overemphasis on technology, and "cream-skimming," and it may also excercise undue influence on national health policy. In this medical market, physicians must act as discerning purchasing agents for their patients and therefore should have no conflicting financial interests. Closer attention from the public and the profession, and careful study, are necessary to ensure that the "medical-industrial complex" puts the interests of the public before those of its stockholders
The private health-care industry is primarily interested in selling services that are profitable, but patients are interested only in services that they need, i.e., services that are likely to be helpful and are relatively safe.
The Medical-Industrial Complex
Arnold Relman
NEJM 1980; 303:963-970
ABSTRACT: The most important health-care development of the day is the recent, relatively unheralded rise of a huge new industry that supplies health-care services for profit. Proprietary hospitals and nursing homes, diagnostic laboratories, home-care and emergency-room services, hemodialysis, and a wide variety of other services produced a gross income to this industry last year of about $35 billion to $40 billion. This new "medical-industrial complex" may be more efficient than its nonprofit competition, but it creates the problems of overuse and fragmentation of services, overemphasis on technology, and "cream-skimming," and it may also excercise undue influence on national health policy. In this medical market, physicians must act as discerning purchasing agents for their patients and therefore should have no conflicting financial interests. Closer attention from the public and the profession, and careful study, are necessary to ensure that the "medical-industrial complex" puts the interests of the public before those of its stockholders
The private health-care industry is primarily interested in selling services that are profitable, but patients are interested only in services that they need, i.e., services that are likely to be helpful and are relatively safe.
In
the health-care marketplace the interests of patients and of society must be
represented by the physician, who alone has the expertise and the authority to
decide which services and procedures should be used in any given circumstance.
We should not allow the medical-industrial complex to distort our health-care system to its own entrepreneurial ends.
We should not allow the medical-industrial complex to distort our health-care system to its own entrepreneurial ends.
Friday, February 9, 2018
Arnold P Gold (1925-2018)
Dr.
Arnold Gold, a pediatric neurologist whose belief in the importance of an
empathetic bedside manner led him and his wife to create a foundation to inspire young doctors
to practice compassionate patient care, died on Jan. 23 in Manhattan.
...
...
“So one day in 1988,” he said in the 2016 interview, “I was
making rounds with the students and residents and a student presented me ‘the
brain tumor in 209.’ And I said: ‘The brain tumor? Isn’t there a child involved
in this? Tell me about the child, tell me about the family. Tell me how this is
impacting on the family. Do you know any of this?’ ” They did not, he said.
At home that night, he told his wife of his concerns about
where medicine was headed. As he recalled, she told him, “You know, Arnold, I’m
tired of you griping about medicine. Do something about it or shut up.”
They began the Arnold P. Gold Foundation together in
Englewood Cliffs, N.J., in 1988, hoping to clone Dr. Gold’s humane approach to
patient engagement.
Saturday, February 3, 2018
Mellanby on Scabies Transmission
Kenneth Mellanby did the classic experiments on scabies transmission during WWII on conscientious objectors. This report in the BMJ, September 1941 is a definite classic. It also shows how concise an important paper can be. About Ken Mellanby.
The Royal Road to Healing
The [Icelandic] Royal Road to Healing: a bit of a saga
Getz L, Kirkengen AL, Petursson H, Sigurdsson JA.
BMJ. 2011 Dec 19;343:d7826. Free Full Text.
In
the face of another person’s suffering, a listener can offer to be a competent,
dedicated, and attentive co-thinker—not pretending to know the solution, but
trusting the healing power inherent in an empathetic relationship.
[This
essay] describes “the healing conversations between Ivar and King Eysteinn that took
place almost 800 years before Sigmund Freud in 1895, formally presented the
“talking cure.” King Eysteinn’s inquisitive style may not follow current advice
regarding open, clinical communication. But it does build an elegant literary
plot, which culminates beautifully, as the king abandons the idea that he can
find the solution to Ivar’s suffering and reveals his insight into the healing
powers of a respectful human relationship.
Monday, January 29, 2018
Living with Motor Neurone Disease: “Where there is life, there is hope”
There's an old Yiddish saying that goes: "Listen to the patient, not the doctor."
In The House of God we are given some laws. Law IV is:
In The House of God we are given some laws. Law IV is:
THE PATIENT IS THE ONE WITH THE DISEASE.
Since this is a commandment, we should listen to our patients.
When Sarah Ezekiel received a diagnosis of motor neurone disease, she
became deeply depressed. Seventeen years later, she describes what
helped her regain hope. Her essay for the BMJ is profound and helpful.
Friday, January 26, 2018
A Bedside Conversation with Wilder Penfield
Alan Blum is a professor of Family Medicine at the University of Alabama School of Medicine at Tuscaloosa He and I have met in cyberspace through our mutual friend, Dr. Dileep Bal of Kapaa, Hawaii. I was researching the great neurosurgeon, Wilder Penfield, when I came across an article by Alan Blum in the Canadian Medical Association Journal in 2011. "A Bedside Conversation with Wilder Penfield."
Blum writes, "Recently, I came across six prescription-size pages of handwritten notes from an hour-long conversation I had with the [Montreal] Institute’s founder, Dr. Wilder Penfield on the morning of Apr. 3, 1976, when he was a patient in the Ross Pavillion at the Royal Vic. Having hoped to meet him since the start of my training, I stopped off at my room after completing night-call and sign-out to muster the courage to introduce myself and to pick up my copy of The Torch, his novel about Hippocrates’ battle to lay the foundations of medicine."
Among other things, Alan Blum is a talented illustrator. We have featured his drawings on Cell 2 Soul in 2010. His recollection of meeting Penfield shortly before the latter's death is moving and worth reading.
Blum writes, "Recently, I came across six prescription-size pages of handwritten notes from an hour-long conversation I had with the [Montreal] Institute’s founder, Dr. Wilder Penfield on the morning of Apr. 3, 1976, when he was a patient in the Ross Pavillion at the Royal Vic. Having hoped to meet him since the start of my training, I stopped off at my room after completing night-call and sign-out to muster the courage to introduce myself and to pick up my copy of The Torch, his novel about Hippocrates’ battle to lay the foundations of medicine."
Among other things, Alan Blum is a talented illustrator. We have featured his drawings on Cell 2 Soul in 2010. His recollection of meeting Penfield shortly before the latter's death is moving and worth reading.
Subscribe to:
Posts (Atom)
Introduction
In 1885, when John Shaw Billings started the database which would, over time, morph into PubMed he recognized the hopelessness o...

-
In 1885, when John Shaw Billings started the database which would, over time, morph into PubMed he recognized the hopelessness o...
-
by James Le Fanu. BMJ 2018;361:k2794 (June 28, 2018) Profligate prescribing has brought a hidden epidemic of si...
-
Isotretinoin: Dose, Duration and Relapse. 30 Years On Marius Rademaker. Australasian Journal of Dermatology (2012)...